3 Followers USX:NVCN - Neovasc Inc Neovasc Inc
Sector: Health Care, Industry: Health Care Equipment
Next Earnings: 8 Aug 2022
Add to Watchlist
   
Add Alert 


Yahoo Finance

USD 5.56    -0.11 (-1.94%)
Show Basic Chart | 3M    6M    1Y    3Y    5Y          

24 May 2022


Loading...
Loading...
Loading...

General

CEO: Mr. Fredericus A. Colen

IPO: 2007-02-05

Headquarters: US

Employees: 49

Homepage

Description

Neovasc Inc is a specialty medical device company. It develops, manufactures and markets products for the rapidly growing cardiovascular marketplace. Its products the Neovasc Reducer (Reducer), for the treatment of refractory angina, which is not currently commercially available in the United States and has been commercially available in Europe since 2015, and the Tiara, for the transcatheter treatment of mitral valve disease, which is under clinical investigation in the United States, Canada, Israel and Europe. The company earns revenue from one source, the Reducer.

Your Holdings
Dashboard
Portfolio
Options
Other Assets

Tools
Screener
Risk Manager
Other Assets
Watchlist
Alerts
Notes
Wall
Community
Forum
Blogs
Instagram
Facebook
Shared Portfolios
Shared Screeners

Collab
Tiger Brokers x StocksCafe
Saxo Trading x StocksCafe
Kenny REIT Screener

Help
Quickstart Guides
StocksCafe Academy
StocksCafe Youtube Channel

About StocksCafe
Our Story
Send Feedback
Pricing
Market
Singapore
Hong Kong
Tokyo
Kuala Lumpur
United States
London
Shenzhen
Shanghai
Bombay
National (India)
Indexes
Singapore Savings Bonds
CoinGecko
Your Account
Settings
Subscriptions
Referrals
Messages
Profile
IG    FB    YouTube

About · FAQs · StocksCafe © 2022 · Privacy · Terms